Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACEIBU trial of intravenous acetaminophen + ibuprofen versus alternating single-agent acetaminophen or ibuprofen after thoracoscopic lung resection
KCT0012021Phase 4Completed
- Sponsor
- Kyongbo Pharmaceutical Co., Ltd
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of acetaminophen and ibuprofen in postoperative pain (2 arms), sponsored by Kyongbo Pharmaceutical Co., Ltd. Primary endpoint: Maximum pain score within 48 hours after surgery. Started Apr 2025; status: completed.
02
Drugs
acetaminophenibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on KCT0012021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012021.